SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 189.65 |
| Enterprise Value ($M) | -95.86 |
| Book Value ($M) | 265.78 |
| Book Value / Share | 5.06 |
| Price / Book | 0.71 |
| NCAV ($M) | 75.72 |
| NCAV / Share | 1.44 |
| Price / NCAV | 2.50 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.41 |
| Return on Equity (ROE) | -0.66 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.93 |
| Current Ratio | 6.93 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 289.31 |
| Assets | 479.37 |
| Liabilities | 213.59 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -277.32 |
| Net Income | -260.49 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -154.18 |
| Cash from Investing | 249.23 |
| Cash from Financing | 0.03 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Perlroth Victor | 10.40 | -13.94 | |
| 13G/A | BlackRock Inc. | 7.70 | -5.95 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 43,312 | 231,777 | 18.69 | |
| 40,701 | 66,931 | 60.81 | |
| 91,109 | 89,654 | 101.62 | |
| 74,233 | 57,521 | 129.05 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| IXHL – Incannex Healthcare Inc. | JANX – Janux Therapeutics, Inc. |
| KALV – KalVista Pharmaceuticals, Inc. | KROS – Keros Therapeutics, Inc. |
| KYMR – Kymera Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io